The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
FOxTROT: Predictive effects of ERBB2 and ERBB3 on neoadjuvant panitumumab benefit in RAS/BRAF wild-type (-wt) locally advanced colon cancer (LACC).
 
Jordan Appleyard
Research Funding - NIHR Academic Clinical Fellowship
Travel, Accommodations, Expenses - Merck Serono
 
Jenny Seligmann
Honoraria - GSK, Merck Serono, Pierre Fabre Medicament, Servier, Takeda
Consulting or Advisory Role - BMS, Johnstone and Johnstone, Merck Serono, GSK, Nanobiotix, Nordic Pharmaceuticals, Sanofi, Servier, Takeda
Research Funding - Amgen, GSK, Pierre Fabre Medicament, Merck Serono, Roche Diagnostics
Travel, Accommodations, Expenses - Takeda
 
Dion Morton
No Relationships to Disclose
 
Faye Elliott
No Relationships to Disclose
 
Kelly Handley
No Relationships to Disclose
 
Bengt Glimelius
No Relationships to Disclose
 
Gemma Hemmings
No Relationships to Disclose
 
Daniel Bottomley
No Relationships to Disclose
 
Philip Quirke
Research Funding - Roche Diagnostics, GeneFirst, Oxford NanoInstrument
Patents, Royalties, Other Intellectual Property - Roche Diagnostics Solutions
Travel, Accommodations, Expenses - Roche Diagnostics Solutions
 
Laura Magill
No Relationships to Disclose
 
Nicholas West
Consulting or Advisory Role - BMS, Astellas, GSK, Amgen, Pfizer, Servier
Research Funding - GSK, Pierre Fabre, Roche Diagnostics
Patents, Royalties, Other Intellectual Property - Roche Diagnostics Solutions
 
Andrew Beggs
Stock and Other Ownership Interests - Kiffick Biomedical Inc
Consulting or Advisory Role - Oxford Nanopore, Check4Cancer
Research Funding - AstraZeneca, Immunocore, NeoGene, GSK
Patents, Royalties, Other Intellectual Property - Patents related to HLA typing, nanopore sequencing of cfDNA
 
Christopher Williams
Honoraria - GlaxoSmithKline; Merck Serono; MJH Life Sciences; Roche Diagnostics Solutions; SERVIER; Tactics MD
Research Funding - GlaxoSmithKline; Merck Serono; Roche Diagnostics Solutions
Patents, Royalties, Other Intellectual Property - Prediction of response to epidermal growth factor receptor-directed therapies using epiregulin and amphiregulin